IgGenix has a total of 15 patents globally, out of which no patents have been granted. Of these 15 patents, more than 93% patents are active. The United States of America is where IgGenix has filed the maximum number of patents, followed by Canada. Parallelly, The United States of America seems to be the main focused R&D center and also USA is the origin country of IgGenix.
IgGenix was founded in 2019. The company’s line of business includes providing professional analytic or diagnostic services for the medical profession.
Do read about some of the most popular patents of IgGenix which have been covered by us in this article and also you can find IgGenix patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over IgGenix patent portfolio.
How many patents does the Founder and CEO of IgGenix have?
The Founder Derek Croote have 12 patents, Jessica Grossman have 0 patent, Kari Nadeau have 6 patents, Richard Boismenu have 3 patents, Stephen Quake have 0 patents and the CEO Bruce Hironaka have 0 patent.How many patents does IgGenix have?
IgGenix has a total of 15 patents globally. These patents belong to 7 unique patent families. Out of 15 patents, 14 patents are active.How Many Patents did IgGenix File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.Year of Patents Filing or Grant | IgGenix Applications Filed | IgGenix Patents Granted |
2022 | 10 | – |
2021 | 5 | – |
How many IgGenix patents are Alive/Dead?
Worldwide PatentsHow Many Patents did IgGenix File in Different Countries?
Countries in which IgGenix Filed Patents
Country | Patents |
United States Of America | 7 |
Canada | 1 |
Where are Research Centers of IgGenix Patents Located?
The Research Centre for all the IgGenix patents is the United States of America.What Percentage of IgGenix US Patent Applications were Granted?
IgGenix (Excluding its subsidiaries) has filed 4 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0.0%. Below are the key stats of IgGenix patent prosecution at the USPTO.Which Law Firms Filed Most US Patents for IgGenix?
Law Firm | Total Applications | Success Rate |
Brown Rudnick | 4 | 0% |
List of IgGenix Patents
IgGenix Patents | Title |
US20230173088A1 | Compositions And Methods For Treating And Suppressing Allergic Responses |
US20230174632A1 | Combinations For Allergy Therapy |
US20220412935A1 | Antigen Testing |
US20220324961A1 | Allergy Therapy |
US20220290240A1 | Methods And Systems For Predicting Allergic Response |
US20220267423A1 | Ige Antibodies Cross-Reactive To Allergens And Tumor Antigens |
US20220153820A1 | Compositions And Methods For Treating And Suppressing Allergic Responses |
WO2023107335A1 | Compositions And Methods For Treating And Suppressing Allergic Responses |
WO2023107216A1 | Combinations For Allergy Therapy |
WO2022271900A1 | Food Antigen Testing |
WO2022221240A1 | Allergy Therapies |
WO2022192625A1 | Methods And Systems For Predicting Allergic Response |
WO2022178260A1 | Ige Antibodies Cross-Reactive To Allergens And Tumor Antigens |
CA3202530A1 | Compositions And Methods For Treating And Suppressing Allergic Responses |
WO2022109093A1 | Compositions And Methods For Treating And Suppressing Allergic Responses |